TECH Malaria, cancer and Crohn's disease drugs to be tested as COVID-19 treatments, WHO says

TECH

Malaria, cancer and Crohn's disease drugs to be tested as COVID-19 treatments, WHO says

CGTN

22:07, August 11, 2021

The hope is to identify new drugs to help treat COVID-19 patients. (Photo: VCG)

Three anti-inflammatory drugs used to treat malaria, some cancers and Crohn's Disease or rheumatoid arthritis are to be part of a clinical trial for potential treatments for COVID-19 patients, the World Health Organization (WHO) has announced.

The drugs – artesunate, imatinib and infliximab – were selected by an independent expert panel for the Solidarity Plus trial because of their potential in reducing the risk of death in hospitalized COVID-19 patients, the WHO said.

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue